How cells' protein-cleanup systems affect Alzheimer's and aging
The Role of Immunoproteasome Function in Alzheimer's Disease and Aging
This project looks at whether a special protein-cleanup system in brain support cells helps protect against Alzheimer's changes as people age.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11137030 on NIH RePORTER |
What this research studies
You'll hear that researchers are studying immunoproteasomes, a specialized protein-clearance machinery in brain support cells (glia), to see how they change with inflammation and aging. They will compare immunoproteasomes to the regular proteasomes and observe how well each clears proteins linked to Alzheimer's, such as amyloid and tau. The team will use lab-grown cells, animal models of Alzheimer's, and analysis of brain tissue to track these changes under inflammatory and oxidative stress conditions. Their experiments aim to determine whether immunoproteasomes are harmful contributors to disease or a helpful compensatory response.
Who could benefit from this research
Good fit: People with Alzheimer's disease or older adults at increased risk who can provide clinical information or donate tissue or samples would be the most relevant participants for related efforts.
Not a fit: People without Alzheimer's symptoms or those not eligible or willing to provide samples are unlikely to see direct benefits from this laboratory-focused project.
Why it matters
Potential benefit: If successful, this work could point to new ways to protect the brain by boosting or targeting protein-clearance systems to slow Alzheimer's progression.
How similar studies have performed: Previous research shows proteasome dysfunction in Alzheimer's models and that modifying protein-clearance pathways can alter disease features, but the specific role of immunoproteasomes remains unclear and somewhat controversial.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Myeku, Natura — Columbia University Health Sciences
- Study coordinator: Myeku, Natura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.